An aqueous extract of withania somnifera root inhibits amyloid β Fibril formation in vitro

Phytotherapy Research

Volumn 26, Issue 1, 2012, Pages 113-117

  Kumar, Suresh ^a,b   Harris, Robin J ^c,d   Seal, Christopher J ^a   Okello, Edward J ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; amyloid ; fibrillogenesis; W. somnifera

Indexed keywords

AMYLOID BETA PROTEIN; THIOFLAVINE; WITHANIA SOMNIFERA EXTRACT;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; IN VITRO STUDY; PLANT ROOT; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PEPTIDES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; MEDICINE, AYURVEDIC; MICROSCOPY, ELECTRON, TRANSMISSION; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLAQUE, AMYLOID; WITHANIA;

SOLANACEAE; WITHANIA SOMNIFERA;

EID: 84855707051     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3512     Document Type: Article

References (29)

1. Ahmad M, Saleem S, Ahmad AS, et al,. 2005. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24: 137-147. (Pubitemid 40605154)
2. Alberts DS, Dorr RT, Wunz TP, et al,. 1991. In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs. Anticancer Drugs 2: 69-77.
3. Bates KA, Verdile G, Li QX, et al,. 2009. Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry 14: 469-486.
4. Bhattacharya A, Ghosal S, Bhattacharya SK,. 2001. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 74: 1-6. (Pubitemid 32008512)
5. Bhattacharya SK, Satyan KS, Ghosal S,. 1997. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 35: 236-239. (Pubitemid 28135409)
6. Choudhary MI, Nawaz SA, Zaheer Ul H, et al,. 2005. Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy. Biochem Biophys Res Commun 332: 1171-1179. (Pubitemid 40798207)
7. Dhuley JN,. 2001. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res 15: 524-528. (Pubitemid 32906438)
8. Glenner GG, Wong CW,. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890. (Pubitemid 14104991)
9. 1-42 peptide: Cholesterol potentiation and aspirin inhibition. Micron 33: 609-626. (Pubitemid 35426586)
10. Harris JR,. 2007. Negative staining of thinly spread biological samples. Methods Mol Biol 369: 107-142. (Pubitemid 350183445)
11. Harris JR,. 2008. Cholesterol binding to amyloid-β fibrils: A TEM study. Micron 39: 1192-1196.
12. Hayat MA,. 2002. Principles and Techniques of Electron Microscopy: Biological Application. Cambridge University Press: Cambridge, 543.
13. Hucul JA, Henshaw EC, Young DA,. 1985. Nucleoside diphosphate regulation of overall rates of protein biosynthesis acting at the level of initiation. J Biol Chem 260: 15585-15591. (Pubitemid 16173181)
14. Jain S, Shukla SD, Sharma K, Bhatnagar M,. 2001. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res 15: 544-548. (Pubitemid 32906444)
15. Jayaprakasam B, Padmanabhan K, Nair MG,. 2010. Withanamides in Withania somnifera fruit protect PC-12 cells from β-amyloid responsible for Alzheimer's disease. Phytother Res 24: 859-863.
16. Kuboyama T, Tohda C, Komatsu K,. 2006. Withanoside IV and its active metabolite, sominone, attenuate Abeta (25-35)-induced neurodegeneration. Eur J Neurosci 23: 1417-1426.
17. Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ,. 2010. In vitro protective effects of Withania somnifera (L.) Dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res 24: 1567-1574.
18. LeVine H,. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Meth Enzymol 309: 274-284.
19. LeVine H,. 2004. The Amyloid hypothesis and the clearance and degradation of Alzheimer's β-peptide. J Alzheimers Dis 6: 303-314.
20. Liu J, Wang ZT, Ji LL,. 2007. In vivo and in vitro anti-inflammatory activities of neoandrographolide. Am J Chin Med 35: 317-328. (Pubitemid 46579086)
21. Lorenzo A, Yankner BA,. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91: 2243-2247.
22. Martínez C, Albet C, Agãndez JA, et al,. 1999. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther 65: 369-376. (Pubitemid 29196538)
23. Masters CL, Simms G, Weinman NA,. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245-4249. (Pubitemid 15053619)
24. Naidu PS, Singh A, Kulkarni SK,. 2006. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res 20: 140-146. (Pubitemid 43266840)
25. Naiki H, Higuchi K, Hosokawa M, Takeda T,. 1989. Fluorometric determination of amyloid fibrils in vitro is using the fluorescent dye, thioflavin T1. Anal Biochem 177: 244-249. (Pubitemid 19088253)
26. Parihar MS, Chaudhary M, Shetty R, Hemnani T,. 2004. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: Prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 11: 397-402. (Pubitemid 38568479)
27. Porat Y, Abramowitz A, Gazit E,. 2006. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67: 27-37. (Pubitemid 43881385)
28. Selko DJ,. 2002. Alzheimer's disease in synaptic failure. Science 298: 789-791.
29. Sopher BL, Fukuchi K, Kavanagh TJ, Furlong CE, Martin GM,. 1996. Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death. Mol Chem Neuropathol 29: 153-168. (Pubitemid 27016926)